Zilver PTX — ® ®
the drug-eluting SFA stent.
Treating p g peripherall a arterial dl disease ( femoral artery (SFA) isn even m re di e (PAD) in t e s ) in the superfici al n’’t easy. Not only is the anato my
uniquely dynamic, but complex lesions and patient comorbidities such as diabetes can make these cases even more difficult.
A new technology has now arrived to meet these challenges: Zilver PTX. It is the only drug-eluting stent for the SFA and has been engineered specifically for the periphery.
new tec nolog has now ar n e ll To learn more, visit the Cook Medical booth at EuroPCR. t Euro Cook Medical—Advancing Leg Therapies. ok Medical dvancing L g Therapies tomee es allenge s
® AO AORTIC INTERINTERVENTION VENTION
CRITICAL ARE
CRITICAL CARE
ENDOSCOPY ENDOSCOP
®
INTERVENTIONAL RADIOLOG
INTERVENTIONAL RADIOLOGY
LEAD MANAGEMENT
LE AD MANAGEMENT PERIPHERAL PERIPHERAL INTERINTERVENTION VENTION SURGER SY URGERY UROLOGY UROLOG HEALTH
WOMEN ’S HEALTH
OMEN’S
© COOK 2010
PI-DADV-PCRZPTX-EN-201012
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100